TY  - CHAP
M1  - Book, Section
TI  - Cancer Chemotherapy and Cytotoxic Agents
A1  - Rollins, Douglas E.
A1  - Blumenthal, Donald K.
PY  - 2016
T2  - Workbook and Casebook for Goodman and Gilman's The Pharmacological Basis of Therapeutics
AB  - Table  Graphic  Jump  Location|Download  (.pdf)|PrintTable  45-3.  AntimetabolitesTYPE  OF  AGENTNONPROPRIETARY  NAMESDISEASEFolic  acid  analogsMethotrexate  (amethopterin)Acute  lymphocytic  leukemia;  choriocarcinoma;  breast,  head,  neck  and  lung  cancers;  osteogenic  sarcoma;  bladder  cancerPemetrexedMesothelioma,  lung  cancerPyrimidine  analogsFluorouracil  (5-fluorouracil;  5-FU),  capecitabineBreast,  colon,  esophageal,  stomach,  pancreas,  head  and  neck;  premalignant  skin  lesion  (topical)Cytarabine  (cytosine  arabinoside)Acute  myelogenous  and  acute  lymphocytic  leukemia;  non-Hodgkin’s  lymphomaGemcitabinePancreatic,  ovarian,  lung  cancer5-aza-cytidineMyelodysplasiaDeoxy-5-aza-cytidineMyelodysplasiaPurine  analogs  and  related  inhibitorsMercaptopurine  (6-mercaptopurine;  6-MP)Acute  lymphocytic  and  myelogenous  leukemia;  small  cell  non-Hodgkin’s  lymphomaPentostatin  (2’-deoxycoformycin)Hairy  cell  leukemia;  chronic  lymphocytic  leukemia;  small  cell  non-Hodgkin’s  lymphomaFludarabineChronic  lymphocytic  leukemiaClofarabineAcute  myelogenous  leukemiaNelarabineT-cell  leukemia,  lymphoma  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/16
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1140226452
ER  -